Bishop John E
- SEC CIK
- 0001308911
In the past year, 3 open-market sale filings worth $109.2K and no purchases.
Current role at each company
- ARDX Ardelyx, Inc.See Remarksas of Aug 25, 2026
- LYRA Lyra Therapeutics, Inc.Chief Technology Officeras of Feb 1, 2024
- FMTX Forma Therapeutics Holdings, Inc.SVP, Chief Technology Officeras of Oct 14, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $109.2K
- 3 filings
- Net
- −$109.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Bishop John E as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ARDX Ardelyx, Inc.
See Remarks3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 (view filing) | Feb 20 | 3 days | Bishop John ESee Remarks | SSale | −3.18K | $5.85 | −$18.6K | −0.9%339.2K after | 3 lots |
| May 22, 2026 (view filing) | May 21 | 1 day | Bishop John ESee Remarks | SSale | −2.31K | $6.27 | −$14.5K | −0.7%336.8K after | |
| Aug 25, 2026 (view filing)7:16 PM ET | Aug 21 | 4 days | Bishop John ESee Remarks | SSale | −19.8K | $3.86 | −$76.2K | −5.9%317.1K after | 2 lots |